New hope for tough blood cancers: LP-118 trial launches
NCT ID NCT04771572
First seen May 06, 2026 · Last updated Jun 16, 2026 · Updated 7 times
Summary
This early-stage study tests a new oral drug, LP-118, in up to 100 adults with blood cancers like lymphoma, leukemia, or myeloma that returned or didn't respond to prior therapy. The main goals are to find the safest dose and see if the drug can shrink tumors or slow the disease. Participants take the drug once daily, and researchers monitor side effects and how the body processes the medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45229, United States
-
University of North Carolina
RECRUITINGChapel Hill, North Carolina, 27514, United States
-
University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.